{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of Flu A + B CLIA Waived Kit",
        "BD Veritor System",
        "BD Veritor System Flu A + B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K180438",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132259",
        "K132692",
        "K151291",
        "K160161"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "February 15, 2018",
    "Summary Letter Received Date": "February 20, 2018",
    "Submission Date": "March 16, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza virus antigen detection test systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "POCT"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Flexible minitip flocked swab",
        "Reaction tube with lysing agent"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor Reader",
        "BD Veritor Plus Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Optoelectronic interpretation",
        "Reflectance-based measurement"
    ],
    "Methodologies": [
        "Immuno-chromatographic assay",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Analyzer",
        "Instrument",
        "Reagent",
        "Reader",
        "Control",
        "Swab",
        "Cartridge",
        "Accessory",
        "Module"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A + B CLIA Waived Kit using chromatographic immunoassay for influenza A and B antigen detection with reader or analyzer interpretation",
    "Indications for Use Summary": "Rapid qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients to aid in the diagnosis of influenza A and B infections",
    "fda_folder": "Microbiology"
}